Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 1
1990 1
2009 1
2010 1
2012 2
2013 2
2014 4
2015 9
2016 6
2017 5
2018 3
2019 8
2020 14
2021 8
2022 5
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Results by year
Filters applied: . Clear all
Page 1
Minimal Change Disease Associated With Durvalumab.
Toda MG, Fujii K, Kato A, Yoshifuji A, Komatsu M, Amino Y, Kitazono S, Hashiguchi A, Ryuzaki M. Toda MG, et al. Among authors: kitazono s. Kidney Int Rep. 2021 Sep 1;6(10):2733-2734. doi: 10.1016/j.ekir.2021.08.021. eCollection 2021 Oct. Kidney Int Rep. 2021. PMID: 34622115 Free PMC article. No abstract available.
Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy.
Ariyasu R, Horiike A, Yoshizawa T, Dotsu Y, Koyama J, Saiki M, Sonoda T, Nishikawa S, Kitazono S, Yanagitani N, Nishio M. Ariyasu R, et al. Among authors: kitazono s. Anticancer Res. 2017 Aug;37(8):4229-4232. doi: 10.21873/anticanres.11814. Anticancer Res. 2017. PMID: 28739711
Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer.
Hasegawa T, Yanagitani N, Ohyanagi F, Kudo K, Horiike A, Tambo Y, Nishikawa S, Ariyasu R, Uchibori K, Kitazono S, Nishio M. Hasegawa T, et al. Among authors: kitazono s. Int J Clin Oncol. 2021 Mar;26(3):507-514. doi: 10.1007/s10147-020-01822-7. Epub 2020 Nov 7. Int J Clin Oncol. 2021. PMID: 33159605 Clinical Trial.
Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab.
Kawashima Y, Nishikawa S, Ninomiya H, Yoshida R, Takano N, Oguri T, Kitazono S, Yanagitani N, Horiike A, Ohyanagi F, Ishikawa Y, Nishio M. Kawashima Y, et al. Among authors: kitazono s. Intern Med. 2019;58(10):1479-1484. doi: 10.2169/internalmedicine.1673-18. Epub 2019 May 15. Intern Med. 2019. PMID: 31092773 Free PMC article.
Advances in the treatment of postoperative recurrence of non-small cell lung cancer and their impact on survival in Asian patients.
Hashimoto K, Ariyasu R, Ichinose J, Matsuura Y, Nakao M, Amino Y, Uchibori K, Kitazono S, Yanagitani N, Okumura S, Nishio M, Mun M. Hashimoto K, et al. Among authors: kitazono s. J Thorac Cardiovasc Surg. 2022 Aug 25:S0022-5223(22)00903-5. doi: 10.1016/j.jtcvs.2022.08.014. Online ahead of print. J Thorac Cardiovasc Surg. 2022. PMID: 36137840
64 results